BEGIN:VCALENDAR VERSION:2.0 PRODID:-//wp-events-plugin.com//7.2.3.1//EN TZID:America/Phoenix X-WR-TIMEZONE:America/Phoenix BEGIN:VEVENT UID:1566@azbio.org DTSTART;TZID=America/Phoenix:20210615T080000 DTEND;TZID=America/Phoenix:20210615T090000 DTSTAMP:20210610T020338Z URL:https://www.azbio.org/events/outsourcing-from-research-to-manufacturin g SUMMARY:AZBioPEERS: Outsourcing - From Research to Manufacturing - - 15 Ju n 21 08:00 DESCRIPTION:\nJoin us for a discussion about outsourcing strategies for res earch\, \; manufacturing\, and supply chain management for life scienc es.\nOutsourcing - From Research to Manufacturing\nTuesday June 15th\, 202 1  \; 08:00 – 09:00 AM\n\nFeatured speakers:\n\nCathy Langham - Pres ident &\; CEO\, Langham Logistics\n\nJoanna Ward - Global External Manu facturing Consultant\, Ward Biotechnology Consulting\, LLC\n\nKristin Bloi nc\, \;PA-C\, MPH\, DVM\, DACVPM- \;Vice President\, Global Resear ch and Exploratory Development Chair\, \;Elanco Foundation\n\nModerato r: George Colberg\, \;President &\; CEO\, Kalos Therapeutics\n\n&nb sp\;\nREGISTER\n \;\nAbout Our Speakers\nCathy Langham\n\nPresident &a mp\; CEO\, Langham Logistics\n\nCathy opened trucking and air freight fran chises 3 years out of college\, then sold them and co-founded Langham Logi stics\, Inc. with her sister and brother.  \;Langham is now a $55+ mil lion global transportation and warehousing business with 180 employees and distribution facilities across the United States. \; Ms. Langham\, a graduate\, of North Central high school and the Kelley School of Business at Indiana University\, shares her logistics expertise with business leade rs in industries including pharmaceutical\, food and beverage\, automotive \, and other sectors with complex supply chains.\n\nCathy is the logistics company’s President and CEO and spends much of her time focused on stra tegic direction\, customer relationships\, and civic leadership. \;&nb sp\; During George Bush’ Presidency\, Langham’s visibility as CEO of a fast-growing business enterprise earned her firm a 2-hour visit from him.  \;In 2005\, she accepted a 6-year role on the Indiana Economic Devel opment Corporation (IEDC) Board at the invitation of Governor Mitch Daniel s. \; In 2015 she Co-chaired Governor Mike Pence’s Blue-Ribbon panel charged with creating and prioritizing the next 10 to 30 years of transpo rtation infrastructure for the State of Indiana.\n\nLangham was Vice chair of the Superbowl in 2012 and is past Chair and Executive Committee member of the Central Indiana Corporate Partnership (CICP)\, President of The Ec onomic Club and Vice President of the Indy Championships Fund. \; Cath y has received several awards: Sagamore of the Wabash\, IU Kelley School o f Business Distinguished Entrepreneur\, EY Entrepreneur of the Year\, the Andre Lacy Vanguard Award for industry acumen and community leadership\, a nd has been inducted into the Central Indiana Business Hall of Fame. \ ; Cathy lives in Carmel with her husband Rick Kocerha (who owns a business in Lafayette IN) and their 21-year-old son\, Stephen\, who attends Butler University.\n\n \;\n\nJoanna Ward \;\n\nGlobal External Manufactu ring Consultant\, Ward Biotechnology Consulting\, LLC\n\n\n\nA committed l eader in the field and dedicated professional with over 25 years of Biotec hnology experience in areas including manufacturing\, validation and Regul atory Compliance. Experienced in establishing complex supply chains for ea rly stage CAR-T cell manufacturing\, and commercial products such as Prove nge (cell therapy)\, Adcetris (ADC) and Trodelvy (ADC) with the use of con tract manufacturing organizations. A career starting in a hospital virolog y laboratory after graduation with a degree Botany\, led to a foot in the door of one of the first Biotechnology CMO’s (Celltech – now Lonza). H aving moved to the USA in late 80’s\, the career path expanded to proces s development and GMP manufacturing for a variety of products at various l eading Biotechnology companies\, from start-ups to large commercial entiti es.\n\n \;\n\n \;\n\nKristin Bloinc\, PA-C\, MPH\, DVM\, DACVPM\n\ nVice President\, Global Research and Exploratory Development Chair\,  \;Elanco Foundation\n\nKristin Bloink is the Vice President of Global Rese arch and Exploratory Development within Research and Development\, at Elan co Animal Health. \; In this role\, she manages internal discovery eff orts\, R&\;D stage external technology evaluations and external researc h collaborations across all product platforms\, to include small molecule\ , biopharma\, vaccine technologies\, and nutritional health opportunities.  \; She also Chairs the corporate non-profit\, Elanco Foundation\, foc used on food security and human animal bond initiatives.\n\nKristin has 30 years of accomplishments in human clinical trials\, animal drug discovery and development\, translational model development and execution\, and hum an and veterinary clinical medical delivery in the private\, academic as w ell as the military sectors. \; Past employers\, with leadership roles have included: University of Michigan - Cranial Base Program\, United Sta tes Army\, Novartis Animal Health\, and several private hospitals/clinicia n groups in both human and veterinary medicine.\n\nOutside of Elanco effor ts\, she helps support the ongoing need for veterinary basic and applied s cience research by serving on the Board of Directors of the American Kenne l Club\, Canine Health Foundation.\n\nShe earned a BS in Human Medicine fr om the University of Iowa\, a MPH from the University of Michigan\, and a DVM from Michigan State University. \; She is a Diplomate of the Ameri can College of Veterinary Preventative Medicine.\n\n\n \;\n\nGeorge Co lberg\n\nPresident &\; CEO\, Kalos Therapeutics\nGeorge Colberg co-foun ded Kalos Therapeutics with Gregory Witchel in 2005. He has developed the corporate philosophy of Kalos\, identified\, and worked to explore the pri mary products\, raised seed\, grant round\, and A round of financing. Geor ge recruited and retained the executive team and scientific advisory board while facilitating the clinical development plan. \; \;He has inv estigated new compounds and constructs for potential licensing or acquisit ion and continues to explore new opportunities for Kalos. \; \;His continuing role in the Company will be to create shareholder value\, pati ent benefits\, promote corporate governance\, assist in establishing corpo rate regulations and controls\, and presiding over executive level functio ns.\n \; \; \; \;George founded and is the former Presiden t and CEO of Primary Care\, Inc.\, one of the first companies to create a solution to the national physician self-referral dilemma. \; \;Pri ce Waterhouse and a regional business journal recognized his contributions with their Up &\; Comer Award in Finance. George \; \;has expe rience in corporate finance and management.\n \;\n CATEGORIES:webinars END:VEVENT BEGIN:VTIMEZONE TZID:America/Phoenix X-LIC-LOCATION:America/Phoenix BEGIN:STANDARD DTSTART:20200615T080000 TZOFFSETFROM:-0700 TZOFFSETTO:-0700 TZNAME:MST END:STANDARD END:VTIMEZONE END:VCALENDAR